Upcoming IPO: Medicap Healthcare Filed DRHP with SEBI to Float ₹240 Crore IPO

Medicap Healthcare has submitted its draft red herring prospectus (DRHP) to the Securities and Exchange Board of India (SEBI), proposing to raise ₹240 crore through an initial public offering (IPO). 

The IPO will consist entirely of a fresh issue of equity shares, with no offer-for-sale (OFS) component, as per the filing made on Monday.

In addition to the IPO, the Vadodara-based company plans to raise ₹48 crore via a pre-IPO placement. Should this placement occur, the size of the fresh issue will be adjusted accordingly.

Use of IPO Proceeds

Proceeds from the IPO will be used to fund the purchase of plant and machinery for its manufacturing facility, repay existing debt of both the company and its subsidiary, KASR Healthcare, and for general corporate purposes.

Also Read: Upcoming IPOs This Week: 11 Mainboard and 17 SME IPOs Set to Open Starting September 22

About Medicap Healthcare

Medicap Healthcare specialises in the production of high-precision packaging components for pharmaceutical companies, including Euro Head caps and bottle preforms. It serves a broad clientele across both domestic and international markets.

The company’s proposed listing aims to support capacity expansion and strengthen its financial position. Aryaman Financial Services has been appointed as the sole book-running lead manager for the issue.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.